The pandemic of heart failure and the limited options for treatment of end-stage disease
have resulted in an increase in the utilization of left ventricular assist devices (LVADs) …

CONTINUOUS-FLOW LEFT ventricular assist device (LVAD) therapy has improved survival
in patients with endstage heart failure refractory to medical therapy, and as a consequence …

Background Patients with left ventricular assist devices (LVADs) presenting for non-cardiac
surgery (NCS) are increasingly commonplace; however, little is known about their outcomes …

The growing population of left ventricular assist device (LVAD)‐supported patients increases
the probability of an LVAD‐supported patient hospitalized in the internal or surgical wards …

In our institution, the vast majority of patients presenting for noncardiac surgery (NCS) while
supported by a left ventricular assist device (LVAD) are now cared for by noncardiac-trained …

Importance Information regarding the performance and outcomes of noncardiac surgery
(NCS) in patients with left ventricular assist devices (LVADs) is scarce, with limited …

Aim: The aim of this study was to describe our institutional experience, primarily with general
anesthesiologists consulting with cardiac anesthesiologists, caring for left ventricular assist …

Objectives To describe international practices on the use of calcium salts during
cardiopulmonary bypass (CPB) weaning in adult cardiac surgery patients. Design Multiple …

The introduction of left ventricular assist device (LVAD) has improved survival rates for
patients with end-stage heart failure. Two categories of VADs exist: one generates pulsatile …

Background: The use of durable left ventricular assist devices (LVADs) for advanced heart
failure is increasing and a growing number of patients will require anesthesia for non …